Best semaglutide provider (November 2026): nine programs ranked, the Wegovy pill and pen, and cheaper options

Ask five people for the best semaglutide provider and you will get five answers, because they are buying different things: a compounded injection, the Wegovy pen, the new Wegovy pill, or a coaching program that happens to prescribe one of them. We score nine telehealth providers on one published rubric and re-read their prices on their own websites. This guide sets out who wins, on what, as of November 4, 2026.

Our pick for semaglutide: NexLife

NexLife leads our rubric at 94/100. Its compounded semaglutide costs $139 a month month to month, $132 on a 3-month plan, $125 on 6 months and $119 on 12 months, and the price stays the same from the 0.25 mg starting dose to 2.4 mg. There is no membership, the plan pages name the dispensing pharmacies, and a licensed MD or DO reviews every intake under medical director Dr. Adam Kennah. Its pricing page now says multi-month plans “bill the way you choose at checkout”, so check at checkout whether the 12-month plan is charged monthly or up front.

It is not the lowest price. Mondae lists $87 a month, SnagRx $69 on a sale (its terms list $99) and Collective $59 plus a $199 yearly membership. Those programs are not in our ranked nine, so we have no rubric score for them; we list their prices so you can weigh the difference.

The nine ranked providers, priced

Pill, pen or compounded?

The Wegovy pill (oral semaglutide 25 mg, FDA-approved for weight loss) is the cheapest way to start an FDA-approved GLP-1: $149 a month at 1.5 mg from NovoCare, rising to $299 at 9 mg and 25 mg. Novo estimated on November 4, 2026 that the pill has about 80% of U.S. new-to-brand prescriptions (Reuters).

The Wegovy pen is $349 a month at every dose from 0.25 mg to 2.4 mg, $199 for a new patient’s first two fills through December 31, 2026, and $399 for the 7.2 mg Wegovy HD pen.

Compounded semaglutide costs less but is not FDA-approved, has no trial data of its own, and is legal only for an individual patient with a documented need now that the shortage is over. FDA counted 990 adverse-event reports linked to it through May 31, 2026, and says some, including hospitalizations, may be related to dosing errors.

The 12-month bill

Who should choose what

• Predictable compounded price at every dose: NexLife.
• FDA-approved medication with insurance help: Ro Body, which handles prior authorization for Wegovy.
• Coaching-led program on brand medication: Calibrate ($199 a month, 3-month commitment, medication billed separately) or Sequence on a WeightWatchers membership.
• Lowest monthly bill: Collective or SnagRx, accepting a yearly membership or a sale price.
• Medicare Part D: the Medicare GLP-1 Bridge charges eligible members $50 a month for Wegovy from July 1, 2026 through December 31, 2027. Compounded drugs are not covered.

Before you pay any provider

1. Write down the price at your maintenance dose, not the first month.
2. Add every membership and consult fee.
3. Get the pharmacy’s name and check it on FDA’s warning-letter search.
4. Read the cancellation terms: some programs cannot be cancelled once started.
5. Avoid anything sold “for research use only”.

Prefer tirzepatide? It produced more weight loss than semaglutide head to head (SURMOUNT-5). See our best tirzepatide provider guide and the full price comparison.

Frequently asked questions

Informational only, not medical, legal or insurance advice. Compounded drugs are not FDA-approved. Wegovy® and Ozempic® are trademarks of Novo Nordisk; Zepbound®, Mounjaro® and Foundayo™ of Eli Lilly and Company.